-
Posted by
Two Blokes Jun 22 -
Filed in
Stock
-
4 views
Concentrix is deeply undervalued, trading at a steep discount to peers despite global scale, diversification, and strong free cash flow potential. Execution on free cash flow targets ($625–650M in 2025) and credible debt reduction are key catalysts for a significant share price re-rating. AI-driven service enhancements and post-acquisition synergies offer upside, but risks include high leverage, modest organic growth, and integration challenges.
